Miami Cancer Institute Summit of the Americas on Immunotherapies for Hematologic Malignancies, Third Annual

Miami, FL US
January 21, 2022 to January 22, 2022

Live Symposium - January 21-22, 2022

ENROLL Today →

Given the increasing frequency of hematologic malignancies, complexities of treatments with novel agents and particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision making and management therefore have become more complex.

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma and stem cell transplantation by novel immunotherapies and treatment combinations. Updates on evolving immunologically and molecular based system therapies will be profiled and discussed.

Educational Objectives

Upon completion of this symposium, participants should be better able to:

  • Summarize the evolving therapeutic strategies in the treatment of hematologic malignancies.
  • Provide an update of new molecular and immunological treatments being developed for these diseases.
  • Discuss the rationale for new targeted diagnostic and therapeutic strategies for lymphoma, myeloma and  leukemia.
  • Review the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic   treatment options.

Who Should Attend

This educational program is directed toward hematologists, oncologists, pathologists, radiation oncologists, palliative care staff, oncology, hematology nurses, pharmacists and other allied health care team members interested in the treatment of patients with hematologic malignancies.

Registration and Fees

 Early RegistrationAfter January 1, 2022 
Baptist Health Employees$55$75
International Physicians$125$125
International Other$95$95

Event date: January 21-22, 2022

ENROLL Today →

Course summary
Available credit: 
  • 9.75 AMA PRA Category 1 Credit™
  • 9.75 General certificate of attendance
Course opens: 
Course expires: 
Event starts: 
01/21/2022 - 7:30am
Event ends: 
01/22/2022 - 12:15pm

Agenda - Friday, January 21, 2022

7:30 - 8:30 a.m.Registration and Continental Breakfast
8:30 - 8:45 a.m.Welcome and Introductions
Guenther Koehne, M.D., Ph.D.
Acute Myeloid Leukemia
8:45 - 9:15 a.m.Treatment Approached for high-risk Acute Myeloid Leukemia in 2022
Richard Stone, M.D.
9:15 - 9:45 a.m.Overcoming Resistance to Targeted therapies in Acute Myeloid Leukemia
Eytan Stein, M.D.
9:45 - 10:15 a.m.Myelofibrosis: Current and Emerging Treatments
Raajit Rampal, M.D.
10:15 - 10:45 a.m.Break and Exhibits
Acute Lymphoid Leukemia
10:45 - 11:15 a.m.Updates on Treatment Approaches for Acute Lymphoblastic Leukemia
Hagop Kantarjian, M.D.
11:15 - 11:45 a.m.Improving Outcomes in T-ALL: Challenges and New Directions
Wendy Stock, M.D.
11:45 a.m. - 12:45 p.m.Lunch and Exhibits
Multiple Myeloma
12:45 - 1:15 p.m.Treatment Approaches for Multiple Myeloma in 2022
Paul Richardson, M.D.
1:15 - 1:45 p.m.Update on BCMA-Directed Therapies for Multiple Myeloma
Adam Cohen, M.D.
1:45 - 2:15 p.m.Wilms’ Tumor antigen 1 in Multiple Myeloma
Guenther Koehne, M.D., Ph.D.
2:15 - 2:45 p.m.Signature Human B-Cell Surface Glycosylation Can Provide Key Insights for Treating B-Cell Malignancies
Charles Dimitroff, Ph.D.
2:45 - 3:00 p.m.Break and Exhibits
Non-Hodgkin Lymphoma
3:00 - 3:30 p.m.Updates on Treatment Approaches in Diffuse Large B-Cell Lymphoma (DLBCL)
Matthew Matasar, M.D.
3:30 - 4:00 p.m.Updates on treatment approaches for Primary (CNS) Lymphoma
Craig Sauter, M.D.
4:00 - 4:30 p.m.Questions and Answers
4:30 p.m.Adjourn

Agenda - Saturday, January 22, 2022

7:30 - 8:30 a.m.Registration and Continental Breakfast
Allogeneic Stem Cell Transplants
8:30 - 9:00 a.m.The role of intestinal microbiome in hematopoietic stem cell transplantation and immuno-oncology
Marcel van den Brink, M.D., Ph.D.
9:00 - 9:30 a.m.The Impact of CAR T-Cell Therapy on Hematopoietic Stem Cell Transplantation
Robert Soiffer, M.D.
CAR Cell Therapies
9:30 - 10:15 a.m.Keynote Address - Next steps in CAR T-cell therapies
Michel Sadelain, M.D., Ph.D.
10:15 - 10:45 a.m.Break and Exhibits
10:45 - 11:15 a.m.Optimizing CAR Cell-based Immunotherapy by Targeting the Cancer Cell “Sugar-Coat”
Robert Sackstein M.D., Ph.D.
11:15 a.m. - 11:45Novel Approaches of CAR T-cell Therapies for AML
Siddhartha Mukherjee, M.D.
11:45 a.m. - 12:15 p.m.Do CARs Always Have to Be T-Cells
Paul Lin, M.D.
12:15 - 12:45 p.m.Questions and Answers
12:45 p.m.Adjourn

NOTE: Schedule subject to change.

Ritz-Carlton Coconut Grove
3300 SW 27th Ave
Miami, FL 33133
United States

About the Venue

Miami might stimulate the mind for glitter and glamour, but it is the city’s Coconut Grove district that serves up its cultural soul. Art galleries, museums, boutiques and restaurants beckon visitors to this historic Florida neighborhood, along with The Ritz-Carlton Coconut Grove, Miami, a hotel destined to enchant every guest with a truly unique hospitality experience. Inspired by the peacock hues of blue, violet and green, the hotel exquisitely blends in to the lush surroundings of this Biscayne Bay artist enclave, making it a work of art itself. Enjoy dining that exemplifies Miami’s diverse mix of cultural flavors. Find inner tranquility with a customized spa experience. Or let the glow of a fire pit and the comfort of an oversized couch make an evening on our Courtyard Fountain Terrace all the more memorable. The Ritz-Carlton Coconut Grove, Miami is also just minutes from first-class shopping and dining in Brickell, Miami.

Symposium Director

Guenther Koehne M.D., Ph.D.Guenther Koehne M.D., Ph.D.
Deputy Director of Miami Cancer Institute
Chief of Blood & Marrow Transplant and Hematologic Oncology
Miami Cancer Institute
Miami, Florida 


Adam D. Cohen, M.D.Adam D. Cohen, M.D.
Assistant Professor of Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
Charles J. Dimitroff, Ph.D.Charles J. Dimitroff, Ph.D.
Executive Associate Dean for Research
Director, Translational Glycobiology Institute at FIU
Professor, Department of Translational Medicine
Herbert Wertheim College of Medicine
Florida International University
Hagop Kantarjian, M.D.Hagop Kantarjian, M.D.
Department of Leukemia
Division of Cancer Medicine
MD Anderson Cancer Center
Paul Lin M.D., Ph.D.Paul Lin M.D., Ph.D.
Instructor at The University of Texas
MD Anderson Cancer Center
Houston, Texas
Matthew J. Matasar, M.D.Matthew J. Matasar, M.D.
Section Lead, Aggressive B-cell Lymphoma
Associate Member, Lymphoma Service
Memorial Sloan Kettering Cancer Center
New York, New York
Siddhartha Mukherjee, M.D.Siddhartha Mukherjee, M.D.
Medical Oncologist
Columbia University
Herbert Irving Comprehensive
Cancer Center
Raajit K. Rampal, M.D., Ph.D.Raajit K. Rampal, M.D., Ph.D.
Associate Member
Clinical Director
Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, New York
Paul Richardson, M.D.Paul G. Richardson, M.D.
Clinical Program Leader and Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Robert Sackstein, M.D.Robert Sackstein, M.D.
Senior Vice President for Health Affairs
Dean, Herbert Wertheim College of Medicine
Florida International University
Miami, Florida
Michel Sadelein, M.D.Michel Sadelein, M.D.
Center for Cell Engineering
Memorial Sloan Kettering
New York, New York
Craig Sauter, M.D.Craig Sauter, M.D.
Hematologic Oncologist
Clinical Director
Adult Bone Marrow Transplant Service
Memorial Sloan Kettering
Robert Soiffer, M.D.Robert Soiffer, M.D.
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Eytan M. Stein, M.D.Eytan M. Stein, M.D.
Assistant Attending Physician
Director, Program for Drug Development in Leukemia
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Wendy Stock, M.D.Wendy Stock, M.D.
Hematologist/ Oncologist
Professor of Medicine
University of Chicago
Chicago, Illinois
Richard M. Stone, M.D.Richard M. Stone, M.D.
Chief of Staff, Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Marcel R. van den Brink, M.D.Marcel R. van den Brink, M.D.
Medical Oncologist
Head, Division of Hematologic Malignancies
Memorial Sloan Kettering

Disclosures And Resolution Of Conflict Of Interest

Disclosure Policy and Disclaimer


Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 9.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.


Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use. ​​

Available Credit

  • 9.75 AMA PRA Category 1 Credit™
  • 9.75 General certificate of attendance


Please login or register to take this course.

COVID-19 Protocols Notice for All Attendees, Exhibitors and Vendors

Please be sure to read our COVID Protocols for all in-person education prior to registering for this activity.

Learn More